IRIS
MARZULLO, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.077
NA - Nord America 3.501
AS - Asia 1.050
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 8
AF - Africa 3
Totale 8.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.476
IE - Irlanda 1.449
SE - Svezia 693
DE - Germania 571
UA - Ucraina 474
IT - Italia 467
CN - Cina 313
FI - Finlandia 282
SG - Singapore 219
HK - Hong Kong 199
IN - India 138
VN - Vietnam 112
GB - Regno Unito 51
IR - Iran 44
FR - Francia 34
CA - Canada 24
BE - Belgio 21
CZ - Repubblica Ceca 15
EU - Europa 15
TR - Turchia 11
JP - Giappone 4
RO - Romania 4
RU - Federazione Russa 4
BR - Brasile 3
ES - Italia 3
KR - Corea 3
NL - Olanda 3
AM - Armenia 2
CL - Cile 2
IL - Israele 2
PH - Filippine 2
AR - Argentina 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
LT - Lituania 1
MK - Macedonia 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 8.654
Salva come PNG Salva come JPEG
Città #
Dublin 1.444
Jacksonville 911
Dearborn 415
Chandler 292
Wilmington 234
Hong Kong 199
Lawrence 180
Princeton 180
Singapore 146
San Mateo 139
Beijing 117
Dong Ket 112
Ann Arbor 87
Ashburn 86
Andover 85
Piemonte 81
Bremen 55
Boardman 48
Helsinki 37
Milan 35
Philadelphia 32
Woodbridge 30
Houston 26
Norwalk 26
Hefei 25
Nanjing 25
Kunming 24
Munich 22
Brussels 21
Zanjan 21
Santa Clara 19
Fairfield 18
Rome 18
Novara 17
Turin 16
Brno 15
Monmouth Junction 15
Guangzhou 14
Toronto 14
Nanchang 13
Jinan 12
Alessandria 11
Espoo 9
Vercelli 9
Ardabil 8
Paris 8
Shenyang 8
Casalecchio Di Reno 7
Düsseldorf 7
Naples 7
Berlin 6
Bologna 6
Borgo Vercelli 6
Napoli 6
Seattle 6
Torino 6
Xian 6
Zhengzhou 6
Augusta 5
Chengdu 5
Hebei 5
Kocaeli 5
Leawood 5
London 5
Nardò 5
Winnipeg 5
Palermo 4
Pescantina 4
West Jordan 4
Baotou 3
Cambridge 3
Cassano Magnago 3
Cuggiono 3
Dallas 3
Florence 3
Grafing 3
Pioltello 3
Rocca San Felice 3
San Diego 3
San Francisco 3
Wenzhou 3
Wuhan 3
Afragola 2
Appiano Gentile 2
Aversa 2
Bagnoli del Trigno 2
Belmont 2
Berbenno Di Valtellina 2
Biella 2
Bulandshahr 2
Busalla 2
Cesena 2
Changsha 2
Colturano 2
Corsico 2
Des Moines 2
Desenzano del Garda 2
Frankfurt am Main 2
Fuzhou 2
Galliate 2
Totale 5.555
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 143
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 103
Cholecalciferol (vitamin D3) has a direct protective activity against interleukin 6-induced atrophy in C2C12 myotubes 87
Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy 86
Prediction of Efficacy of Octreotide Therapy in Patients with Acromegaly 82
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 79
Acute Vitamin D₃ Supplementation in Severe Obesity: Evaluation of Multimeric Adiponectin 75
Reversibility of joint thickening in acromegalic patients: an ultrasonography study 74
Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life 74
Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS) 72
Cardiovascular aspects in acromegaly: effects of treatment 71
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 71
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure 70
Transsphenoidal surgery for pituitary adenomas: early results from a single center 69
Acute and chronic effects of octreotide on thyroid axis in GH-secreting and clinically nonfuctioning pituitary adenomas 68
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 68
[Preliminary data on the effectiveness of resveratrol in a new formulation in treatment of hot flushes] 66
Thyroid cancer phenotypes in relation to inflammation and autoimmunity 66
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 66
Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison to patients without Cushing's disease. 64
Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study 64
Effect of octreotide pretreatment on surgical outcome in acromegaly 64
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 64
CV 205-502 treatment in therapy-resistant acromegalic patients 63
Cardiac effect of thyrotoxicosis in acromegaly 62
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly 62
One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study. 62
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy 62
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 62
Altered multisensory temporal integration in obesity 61
Long-term effect of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly 61
Muscle sympathetic nerve activity in patients with acromegaly 60
Embolization for Insulinoma in Complicated Severe Obesity: Description of an Inoperable Case and Review of the Literature 60
Long-term echocardiographic and cardioscintigraphic effects of growth hormone treatment in adults with Prader-Willi syndrome 60
Acromegaly and prostate cancer 59
Clinical picture and the treatment of TBI-induced hypopituitarism 59
Comparison among different dopamine-agonists of new formulation in clinical management of macroprolactinomas 58
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) 58
Comment on prostatic hyperplasia in patients with acromegaly 58
Percutaneous ethanol injection under Power Doppler ultrasound assistance in the treatment of autonomously functioning thyroid nodules 57
Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity 57
The pathophysiology of abdominal adipose tissue depots in health and disease 57
Analysis of Predictive Equations for Estimating Resting Energy Expenditure in a Large Cohort of Morbidly Obese Patients 57
Early vascular alterations in acromegaly 56
Circulating adipokines and metabolic setting in differentiated thyroid cancer 56
Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases 56
The impact of the metabolic phenotype on thyroid function in obesity 55
Mechanisms in endocrinology: The crosstalk between thyroid gland and adipose tissue: Signal integration in health and disease 55
Plasma Oxytocin Concentration in Pre- and Postmenopausal Women: Its Relationship with Obesity, Body Composition and Metabolic Variables 55
The lullaby of the sun: the role of vitamin D in sleep disturbance 55
Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients 55
Simultaneous and bilateral inferior petrosal sinus sampling for the diagnosis of Cushing's syndrome: comparison of multihormonal assay, baseline multiple sampling and ACTH-releasing hormone test 54
Acylated ghrelin decreases during acute exercise in the lean and obese state 54
Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients 54
Assessment of fat-free mass from bioelectrical impedance analysis in men and women with Prader-Willi syndrome: cross-sectional study 54
Prostatic hyperplasia: an unknown feature of acromegaly 53
Acromegaly and immune function 53
Acromegalic axial arthropathy: a clinical case-control studY 53
Vitamin D as a Biomarker of Ill Health among the Over-50s: A Systematic Review of Cohort Studies. 53
Is Caloric Restriction Associated with Better Healthy Aging Outcomes? A Systematic Review and Meta-Analysis of Randomized Controlled Trials 53
Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia 53
Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing GH excess and deficiency in adults 52
Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome 52
Non-surgical ablative therapies for inoperable benign insulinoma 52
Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome 52
Effects of one-year treatment with octreotide on cardiac performance in patients with acromegaly 52
Metabolic alterations in patients who develop Traumatic Brain Injury (TBI)-induced hypopituitarism. 51
Vitamin D and neurological diseases: An endocrine view 51
New medical approaches in pituitary adenomas 50
Preface 50
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. 50
Serum uric acid potentially links metabolic health to measures of fuel use in lean and obese individuals 50
Effect of growth hormone on cardiac function 49
Increased arterial intima media thickness by M-B-mode echoDoppler ultrasonography in acromegaly 49
Deep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot 49
Lymphocytes and immunoglobulin patterns across the threshold of severe obesity 49
Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities 49
Lack of association between the tetranucleotide repeat polymorphism in the 3'-flanking region of the leptin gene and hypertension in severely obese patients 48
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. 48
Dynamics of GH secretion during incremental exercise in obesity, before and after a short period of training at different work-loads 48
Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome 48
Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations 48
Is growth hormone bad for your heart: Cardiovascular impact of GH deficiency and excess 47
Obesity modifies expression profiles of metabolic markers in superficial and deep subcutaneous abdominal adipose tissue depots 47
The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure 47
Malattie ipotalamo-ipofisarie 46
Abdominal fat index by ultrasound does not estimate the metabolic risk factors of cardiovascular disease better than waist circumference in severe obesity. 46
Diagnosis and treatment of GH deficiency in Prader–Willi syndrome 46
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 46
Dynamic tests in pituitary endocrinology: pitfalls in interpretation during aging 46
Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients 45
Growth hormone deficiency in treated acromegaly 45
null 45
Methimazole Treatment and Risk of Acute Pancreatitis: A Population-based Cohort Study 45
Immunomodulatory effects of vitamin d in thyroid diseases 45
Insights into non-classic and emerging causes of hypopituitarism 45
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly 44
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas 44
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome 44
Growth hormone deficiency in children 44
Totale 5.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.485 0 0 0 0 257 255 371 84 180 174 160 4
2020/20211.301 151 1 171 3 176 60 177 8 190 27 193 144
2021/20221.281 43 27 214 137 60 26 108 40 105 31 216 274
2022/20232.752 199 108 178 66 194 200 71 135 1.438 11 90 62
2023/2024801 69 80 53 18 150 16 192 25 18 8 55 117
2024/2025284 44 27 105 86 22 0 0 0 0 0 0 0
Totale 8.847